Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 10111748 | Other Grant/Funding Number | UKRI |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| CARE Fertility UK | OTHER |
Not provided
Not provided
Not provided
Not provided
Purpose: This study aims to test whether a new automated system can freeze human eggs and embryos as effectively as the current manual method performed by laboratory staff.
Background: Currently, freezing eggs and embryos during fertility treatments (IVF/ICSI) is done entirely by hand by skilled embryologists. This manual process is time-consuming, requires extensive training, and outcomes can vary between different staff members. Automating this process could help standardize procedures, reduce costs, and potentially make fertility treatments more accessible to patients.
What is Being Tested: The study will compare an automated freezing system (prototype designation PRESERVE-CR) against the standard manual freezing method. The key research question is: Can the automated system preserve eggs and embryos as successfully as experienced embryologists do by hand?
How It Works: Patients undergoing IVF/ICSI treatment at CARE Fertility Manchester who consent to participate will have their surplus eggs and embryos (those not suitable for their treatment) divided into two groups. Some will be frozen using the traditional manual method, and some using the new automated system. Both groups will then be thawed to measure survival rates. Tests do not encompass any reproductive outcomes or the creation of embryos specifically for this research.
Why This Matters: If successful, automated freezing could help reduce the workload on laboratory staff, standardize the freezing process across different clinics, potentially lower treatment costs, and make fertility treatments available to more people who need them. The study only uses oocytes and embryos which are unsuitable for patient treatment and that would otherwise be discarded, ensuring no impact on participants' actual fertility treatment.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Automated Vitrification | Experimental | Oocytes/embryos from a particular donor will be randomized to manual or automated vitrification. There will be no randomization at the patient level |
|
| Manual Vitrification | Active Comparator | Oocytes/embryos from a particular donor will be randomized to manual or automated vitrification. There will be no randomization at the patient level |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Automated Vitrification | Device | The PRESERVE-CR system performs automated vitrification (ultra-rapid freezing) of human oocytes and embryos using robotic manipulation and computer-controlled timing. |
| Measure | Description | Time Frame |
|---|---|---|
| Cryosurvival | The proportion of eggs and embryos that survive the freezing and thawing process when using the PRESERVE-CR automated system compared to manual vitrification (sibling controls). | Within 14 days of egg retrieval |
| Measure | Description | Time Frame |
|---|---|---|
| Procedural Timing | Time required to complete automated vs manual vitrification procedures | Within 14 days of egg retrieval. |
| Morphological Quality Assessment | Visual evaluation of egg/embryo structure and appearance post-thaw |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Giuseppe Silvestri, PhD | Contact | +44 7990960731 | giuseppe@conceivable.life |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CARE Fertility | Recruiting | Manchester | United Kingdom |
Individual participant data that underlie the results reported in an article, after de-identification (text, tables, figures, and appendices).
Data sharing is subject to ethical, legal, and privacy considerations. We are committed to following established guidelines and best practices for data sharing.
Not provided
Beginning 9 months and ending 36 months following article publication.
Researchers who provide a methodologically sound proposal, to achieve aims in the approved proposal.
Proposals may be submitted up to 36 months following article publication. Proposals should be directed to PI@Conceivable.life; to gain access, data requestors will need to sign a data access agreement.
Not provided
Not provided
| ID | Term |
|---|---|
| D007246 | Infertility |
| ID | Term |
|---|---|
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
Not provided
Not provided
A single cohort of patients undergoing IVF/ICSI treatment has their spare eggs and embryos (those not suitable for treatment) divided for parallel assignment to two study arms. Each patient's samples are split, with some assigned to automated vitrification using the PRESERVE-CR system and some assigned to standard manual vitrification. This parallel design using sibling samples allows direct comparison of the two methods while controlling for patient-specific factors.
Not provided
Not provided
Not provided
| Manual Vitrification | Device | Control specimens are vitrified by standard vitrification protocol. |
|
| Within 14 days of egg retrieval |
| Technical Performance Metrics | Level of autonomy achieved (percentage of procedures completed without operator intervention outside of UI input). Operator assistance (frequency and type of manual interventions, if any). Success rates of specific robotic actions (picking, placing, plunging). | Within 14 days of egg retrieval. |